Healing time can be lengthened by factors that are intrinsic, for example, diabetes or the nature of the initial injury such as burn depth, and extrinsic, such as infection or smoking. The negative effects of tobacco smoking on acute wound healing have long been analyzed. Cigarette smoke contains more than 250 toxins, all of which are known to impair wound healing, through multiple mechanisms. The literature shows that smoking decreases tissue oxygenation and aerobe metabolism temporarily. The inflammatory healing response is attenuated by a reduced inflammatory cell chemotactic responsiveness, migratory function, and oxidative bactericidal mechanisms.1 The relationship of smoking and delayed postoperative wound healing has been established in numerous prospective and retrospective cohort studies, and the current meta-analysis shows that postoperative healing complications occur significantly more often in smokers compared with nonsmokers.2 Following surgery, patients who smoke usually present delayed wound healing and increased frequency of associated complications, such as skin and flap necrosis, infection, and dehiscence.3–6 Similarly, literature meta-analyses report that an abstinence from smoking of at least 3 to 4 weeks reduces wound healing complications.7,8
Phenol has been used clinically for many years, primarily to create controlled chemical burns of the skin or skin appendages. Two examples are chemical facial peels and nail matrix cauterization (chemical matrixectomy). Phenol is a weak acid that causes denaturation and precipitation of the skin’s proteins but without full-thickness dermal loss. Prolonged skin contact with phenol can, however, cause deep burns with enhanced inflammatory response and drainage and can elicit denaturation and gangrene followed by necrosis.9
Currently, chemical matrixectomy is one of the most common surgical procedures used to correct onychocryptosis or ingrown toenails. The advantages of phenol ablation include lower recurrence rates, performable in the presence of sepsis, less postoperative pain because of its aesthetic properties, and superior cosmetic results. The procedure has a number of disadvantages, however, resulting from the chemical cauterization of the tissue. These include delayed healing, prolonged serous drainage due to the acute reaction to the chemical agent, and increased risk of infection.10 Indeed, some cases of full-thickness burns to the great toe following phenol ablation for an ingrown toenail resulting in amputation have been reported in the literature.11
Numerous modifications of the required concentrations and application times of phenol have been proposed to reduce the drawbacks of the technique. Some studies have described the advantages of using concentrations that are just sufficient to ensure the effectiveness of the technique, while minimizing its drawbacks,12–15 and others have proposed curettage of the cauterized tissue following segmental phenolization to accelerate cicatrization.16
Only a few reports were found in the literature that address the impact of tobacco smoking on cutaneous procedures using chemical agents or laser treatments, and some of them find no differences in smokers versus nonsmokers.17,18 To date, the authors have not found any controlled study analyzing the influence of smoking on cicatrization in patients undergoing nail matrix segmental phenolization. Therefore, the objective of this study was to conduct a prospective randomized clinical investigation to examine how tobacco smoking influences cicatrization following segmental phenolization. By reading this article, clinicians will better understand the effects of smoking on wound healing, specifically in burns after segmental phenolization.
A prospective clinical study was conducted to analyze wound healing time after segmental phenolization in smoker versus nonsmoker patients. From October 2009 to January 2012, all the patients admitted with ingrown toenails in the Área Clínica de Podología of the University of Seville and in the San Lazaro Hospital (Seville, Spain) were included as candidates for a randomized, double-blind, parallel-control-group clinical trial. A selection was made of those who presented ingrown toenails that had previously received conservative treatment (removal of the ingrown nail spicule and local antiseptic treatment) without definitive results.
The study was conducted according to the guidelines of the Declaration of Helsinki19 and the European Guidelines for Good Clinical Practice on Ethical Conduct in Research Involving Humans20 and was approved by the Ethics and Experiment Committee of the University of Seville (CEE 875/US). Informed consent was obtained from all the patients, including consent for publication of photographs.
Randomization was administered by an independent party, which assigned consecutive numbers to the patients’ histories selected at random. This ensured that no member of the team was aware of the following allocation. Patients were randomly assigned between the 2 trial treatments as follows: even clinical history number = the patient’s nail fold or folds underwent segmental phenolization; odd clinical history number = the patient’s nail fold or folds underwent segmental phenolization plus curettage of the matrix and nail bed.
The criteria for inclusion in the study were as follows: Stage I, II, or III ingrown toenail, according to the classification proposed by Kline.21 The exclusion criteria were as follows: patients exposed to secondhand smoke (someone in their home smokes), infected ingrown toenail with partial onycholysis of 1 or both nail borders, clotting problems, wound cicatrization disorders, uncontrolled diabetes (hemoglobin A1c [HbA1c] >7.5%), underlying bone pathology, allergy to local anesthetics, and treatment with steroids or immunosuppressants. Age was not a basis for exclusion.
The primary outcome parameter was the wound healing time after segmental phenolization, distinguishing between smoker and nonsmoker patients. The secondary outcome parameter was the influence of curettage of the cauterized tissue on healing time in both the aforementioned groups.
The surgical procedure consisted of partial ablation from segmental phenolization of the affected nail folds as follows. A digital block of the hallux was performed using 2% mepivacaine (Scandinibsa; Inibsa SA, Barcelona, Spain). After surgical lavage of the operative field, a digital tourniquet was applied for local hemostasis. Using a Freer elevator, the affected nail plate was conveniently separated from the nail bed and eponychium. Partial ablation of the nail plate was performed using a nail splitter and a hemostat. After removal of the portion of the nail, a cotton ball soaked in 100% phenol was applied with a swab for 1 minute to the matrix and the nail bed. The zone was then irrigated with 76% ethanol for 1 minute and then with physiological saline solution. In the experimental group, a Martini bone curette was used to carefully remove all cauterized tissue that had a whitish appearance. This procedure was performed on both nail folds of the hallux when the treatment was bilateral (80 cases) or on one when it was unilateral (13 cases). All the patients received oral antibiotic prophylaxis 60 minutes before the procedure in a single dose of cephalexin 2 g, or 500 mg levofloxacin if the patient was allergic to penicillin. All surgical wounds were dressed with a thin layer of sulfadiazine silver cream and covered with a sterile and nonadherent polypropylene dressing. Three gauzes were placed around the hallux and covered with a sterile compressive bandage.
All the procedures were performed by the same clinician (J.A.-J.). Clinical efficacy and adverse effects were evaluated by a single observer (A.C.-F), who was blinded as to which procedure had been applied. Healing was monitored for spontaneous wound closure by clinical assessments and by digital photographs over 1 month. Patients were seen every 48 hours. From the fourth day onward, the treatment administered to both groups consisted of applying povidone-iodine antiseptic solution. Daily checks were made until the healing time criteria were completely satisfied. The clinical criteria of early healing time were considered to be absence of drainage (no exudate evident), granulation tissue covered by a scab (no evidence of hypergranulation tissue), and no signs of infection (ie, no pain or clinical evidence of discharge in association with redness extending proximally). The patient was then allowed to bathe. All criteria had to be met before the wound was considered cicatrized (ie, healed). Similar criteria have been used in other clinical trials for matrix phenolization wounds.22,23
The sample size required for the study was calculated using the computer program CTM-1.1 (Glaxo Wellcome SA, Madrid, Spain). The result of the computation was that, to detect a clinically relevant difference of 5 days in mean healing time between the experimental and control groups for a significance level of α = .05 and an error β = .15, a minimum of 19 patients would be necessary in each group.
Statistical analyses were performed using SPSS 17.0 (SPSS Science, Chicago, Illinois). A first exploratory analysis was made of the data to detect outliers and to characterize differences between subgroups of individuals. The χ2 test was applied for the variables “sex” and “diabetes,” and the Mann-Whitney U test for the variable “age” to check the homogeneity of the groups (“phenolization” and “curettage”) and subgroups (“smokers” and “nonsmokers”), so as to ensure that any differences in the dependent variables were because of the independent variable and not the heterogeneity of the groups. For all 3 variables, the result was P > .05, so the groups could be considered homogeneous and therefore comparable for inferential analyses.
Quantitative variables were summarized in terms of their means and SDs; qualitative variables were expressed as percentages. The Mann-Whitney U test was applied for comparisons of the variable “healing time” (measured in days). Between-group differences were considered statistically significant when P < .05.
Three patients of the phenolization group were excluded from completion of the study because they presented a clinical pattern of postoperative infection. The final study sample included 90 patients, of whom 51 were nonsmokers and 39 smokers (participant flow and reasons for exclusion are shown in Figure 1). The phenolization group comprised 44 patients (88 nail folds); the curettage group comprised 46 patients (85 nail folds). The general features of patients regarding sex, treatment received, number of operated nail folds, and smoker or nonsmoker are given in Table 1.
The primary outcome parameter analyzed was the wound healing time after segmental phenolization in smoker and nonsmoker patients as described in Methods. The secondary outcome parameter analyzed was the influence of curettage of the cauterized tissue on healing time in the 2 groups of patients.
In both treatment groups, the healing time was significantly longer (P < .0001) in the smokers than in the nonsmokers. It was also significantly longer in patients who underwent phenolization alone than in those who also underwent curettage. This latter difference was also found to be statistically significant (P < .0001) when comparing only the smokers of the 2 treatment groups (phenolization vs curettage).
The healing times and their distribution in each group are listed in Tables 2 to 5.
Although numerous clinical and experimental studies have examined the effect of nicotine on wound healing and surgical procedures, there are few published reports in the dermatological surgery literature.24 The evidence now shows that tobacco smoking is associated with a higher incidence of postoperative complications including wound dehiscence, flap or graft necrosis, prolonged healing time, and infections.1–8
With respect to the impact of smoking on cutaneous procedures using phenol, in 1983, Klein and Little25 reported a case series of 3 chronic smokers who developed laryngeal edema manifesting as stridor, hoarseness, and shortness of breath as a complication after phenol peels. Besides this single case series, there are no other reported associations between smoking and chemical cutaneous cauterization with phenol in the literature.25
Several studies have examined mean healing time after segmental phenolization, but the results they report are disparate, and they use different criteria as to what is meant by a healed or cicatrized wound.12–16 In the present study, conducted to evaluate the effects of smoking on wound healing after segmental phenolization, the authors applied early cicatrization criteria similar to those used in other clinical trials. The results show that healing times are significantly longer in smokers than in nonsmokers, independently of whether the patient underwent phenolization alone or phenolization followed by curettage.
In a clinical trial, Sorensen et al26 demonstrated that smoking has a transient effect on the tissue microenvironment but a prolonged effect on cellular inflammatory and reparative functions, leading to delayed healing and complications. Cessation of smoking restores the tissue microenvironment rapidly and the cellular inflammatory functions within 4 weeks, but the proliferative response remains impaired.26 A similar study conducted by that same research group showed that wound contraction and collagen metabolism are disturbed by smoking because of a decrease in vitamin C and a change in inflammatory cell response.27 This would explain why in the present study the wound healing process of the smoker group was observed to be slowed down, possibly due to a temporary stagnation of the acute inflammatory phase of healing.
Phenol’s potential toxic effects and the intense inflammatory changes that it produces in the skin increase inflammation and delay wound healing.11 The excessive inflammatory response caused in part by the toxic effect of phenol on the wound and in part by the altered inflammatory phase of healing originated by smoking would explain the longer healing times the authors observed in the group of smokers who underwent segmental phenolization alone. Furthermore, the authors believe that curettage of the tissue cauterized by phenol restores the tissue microenvironment and cellular inflammatory functions with the consequent immediate reactivation of the inflammatory phase and subsequent fibroplasia, thus speeding up the repair process. Indeed, the results showed that the wounds healed faster with curettage of the cauterized tissue in both the smoker and the nonsmoker groups. Based on these results, the authors propose that curettage should systematically be performed after segmental phenolization to reduce the healing time of smoker patients.
There have been few studies conducted to determine the optimal concentration of phenol to reduce the inflammatory response, drainage, and risk of infection. Boberg et al12 established that the destructive effects of phenol depend in part on its concentration, but that there is no linear relationship between skin necrosis and phenol concentration. That study showed that the application of 89% phenol solution for 1 minute is the minimum time and concentration required for complete destruction of the germinal nail matrix. Similarly, Tatlican et al15 compared different lengths of 89% phenol application to determine the efficacy and safety of the technique. The best results with regard to postoperative complications (pain, drainage, and tissue damage) and complete cure times were obtained in the group to which phenol was applied for 1 minute, with mean complete cure times similar to the healing times obtained in the authors’ phenolization group of nonsmoker patients with pure phenol application.
Most recommendations for smokers who are to undergo surgery are based on evidence suggesting that smoking-related complications can be significantly reduced when the patient abstains for at least 3 to 4 weeks before surgery.7,8 However, there have been no controlled studies examining the time for the reversal of nicotine-induced wound complications when exposure to nicotine ceases. The evidence suggests that perioperative smoking cessation intervention reduces surgical site infections, but not other healing complications.2 The optimal duration of preoperative smoking cessation for reducing wound complications is unclear. Existing evidence suggests that the optimal duration of preoperative cessation is 4 to 8 weeks.28–30 One recent article on chemical peels and laser resurfacing advocates stopping smoking from 1 month before to 6 months after the procedure, but without providing literature to support this suggestion.31
Furthermore, there have been studies showing that, despite warnings from physicians to cease smoking, a large proportion of patients will continue to smoke.30,32 Given those results, some authors recommend that, for heavy smokers who are unable to quit, it may be more practical to recommend that they cut down to less than 1 pack per day.24 In the present study, there were more nonsmokers than smokers (51 vs 39), of whom more than 75% reported consuming more than 1 pack of cigarettes per day. The authors agree with most authors that, despite any recommendations that they might offer patients, a large proportion of them will continue to smoke. Although smoking is certainly not recommended in surgical patients, the authors consider that it may be more reasonable to ask patients to cut down rather than abstain completely. A limitation of this study is that, although it was recommended reducing consumption of cigarettes to smokers of more than 1 pack per day, no reliable test was made to verify if this occurred.
It is commonly accepted that good blood glucose control is required to facilitate the healing of diabetic foot wounds. Several studies have suggested that phenol matrixectomies may be safely performed on patients with diabetes who do not have severely compromised arterial outflow.33,34 Their results indicated no significant difference in healing times or postoperative infection rates. Unfortunately, these retrospective studies evaluated only fasting blood level glucose, but it was not an exclusion criterion. In the present study, the presence of uncontrolled diabetes (HbA1c >7.5%) was a criterion for exclusion so the results are not comparable. Additional studies are necessary to correlate healing times in chemical matrixectomies to HbA1c values. Nevertheless, in the authors’ study, the 2 treatment groups and the age, sex, and presence or absence of diabetes subgroups were homogeneous, so that it can be suspected that the presence of diabetes was neither a confounding factor nor a source of bias in the results.
In conclusion, the segmental phenolization burn wounds of smoker patients take longer to heal than those of nonsmokers. Curettage of the cauterized tissue after segmental phenolization shortens healing time in both smokers and nonsmokers. Therefore, curettage after phenolization should be systematically considered in patients who smoke to reduce the healing time following the procedure.
* Tobacco smoking is associated with a higher incidence of postoperative complications including wound dehiscence, flap or graft necrosis, prolonged healing time, and infections.
* Smokers may reduce smoking-related complications by abstaining from smoking 3 to 4 weeks before their surgery.
* Research has shown that wound contraction and collagen metabolism are disturbed by smoking because of a decrease in vitamin C and a change in inflammatory cell response.
* Burn wounds of smokers take longer to heal than those of nonsmokers. Curettage of the cauterized tissue reduces healing time and should be systematically considered.
* Study results demonstrate that results showed that the wounds from nail matrix phenolization healed faster with curettage of the cauterized tissue in both the smoker and the nonsmoker groups.
1. Shabanzadeh DM, Sorensen LT. Laparoscopic surgery compared with open surgery decreases surgical site infection in obese patients: a systematic review and meta-analysis. Ann Surg 2012; 256: 934–45.
2. Sorensen LT. Wound healing and infection in surgery. The clinical impact of smoking and smoking cessation: a systematic review and meta-analysis. Arch Surg 2012; 147: 373–83.
3. Chan LK, Whithey S, Butler PE. Smoking and wound healing problems in reduction mammoplasty: is the introduction of urine nicotine testing justified? [published correction appears in Ann Plast Surg 2006;56:358] Ann Plast Surg 2006; 56: 111–5.
4. Cropley M, Theadom A, Pravettoni G, Webb G. The effectiveness of smoking cessation interventions prior to surgery: a systematic review. Nicotine Tob Res 2008; 10: 407–12.
5. Goodwin SJ, McCarthy CM, Pusic AL, et al. Complications in smokers after postmastectomy tissue expander/implant breast reconstruction. Ann Plast Surg 2005; 55 (1): 16–19.
6. Sorensen LT, Karlsmark T, Gottrup F. Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg 2003; 238 (1): 1–5.
7. Wong J, Lam DP, Abrishami A, Chan MT, Chung F. Short-term preoperative smoking cessation and postoperative complications: a systematic review and meta-analysis. Can J Anaesth 2012; 59: 268–79.
8. Mills E, Eyawo O, Lockhart I, Kelly S, Wu P, Ebbert J. Smoking cessation reduces postoperative complications: a systematic review and meta-analysis. Am J Med 2011; 124: 144–54.
9. Fisher AA. Irritant and toxic reactions to phenol in topical medications. Cutis 1980; 26: 390–2.
10. Rounding C, Hulm S. Surgical treatments for ingrowing toenails. Cochrane Database Syst Rev 2000; 2: CD 001541.
11. Sugden P, Levi M, Rao GS. Onychocryptosis-phenol burn fiasco. Burns 2001; 27: 289–92.
12. Boberg JS, Frederiksen MS, Harton FM. Scientific analysis of phenol nail surgery. J Am Podiatr Med Assoc 2002; 92: 575–9.
13. Bostanci S, Kocyigit P, Gürgey E. Comparison of phenol and sodium hydroxide chemical matricectomies for the treatment of ingrowing toenails. Dermatol Surg 2007; 33: 680–5.
14. Bos AM, van Tilburg MW, van Sorge AA, Klinkenbijl JH. Randomized clinical trial of surgical technique and local antibiotics for ingrowing toenail. Br J Surg 2007; 94: 292–6.
15. Tatlican S, Yamangokturk B, Eren C, Eskioglu F, Adiyaman S. Comparison of phenol applications of different durations for the cauterization of the germinal matrix: an efficacy and safety study. Acta Orthop Traumatol Turc 2009; 43: 298–302.
16. Álvarez-Jiménez J, Córdoba-Fernández A, Munuera PV. Effect of curettage after segmental phenolization in the treatment of onychocryptosis: a randomized double-blind clinical trial. Dermatol Surg 2012; 38: 454–61.
17. Naouri M, Atlan M, Perrodeau E, et al. High-resolution ultrasound imaging to demonstrate and predict efficacy of carbon dioxide fractional resurfacing laser treatment. Dermatol Surg 2011; 37: 596–603.
18. Hsu TS, Zelickson B, Dover JS, et al. Multicenter study of the safety and efficacy of a 585 nm pulsed-dye laser for the nonablative treatment of facial rhytides. Dermatol Surg 2005; 31 (1): 1–9.
19. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, and amended by the 55th WMA General Assembly, Tokyo, Japan, October 2004; 59th WMA General Assembly Seoul, Republic of Korea, October 2008; and 64th WMA General Assembly, Fortaleza, Brazil, October 2013.
20. The Oviedo Convention on Human Rights and Biomedicine, Oviedo, Spain, April 1997.
21. Kline A. Onychocryptosis: a simple classification system. Foot Ankle J 2008; 1: 6–13.
22. Dovison R, Keenan AM. Wound healing and infection in nail matrix phenolization wounds. Does topical medication make a difference? J Am Podiatr Med Assoc 2001; 91: 230–3.
23. Córdoba-Fernández A, Rayo-Rosado R, Juárez-Jiménez JM. The use of autologous platelet gel in toenail surgery: a within-patient clinical trial. J Foot Ankle Surg 2010; 49: 385–9.
24. Gill JF, Yu SS, Neuhaus IM. Tobacco smoking and dermatologic surgery. J Am Acad Dermatol 2013; 68: 167–72.
25. Klein DR, Little JH. Laryngeal edema as a complication of chemical peel. Plast Reconstr Surg 1983; 71: 419–20.
26. Sorensen LT, Toft B, Rygaard J, Teisner B, Gottrup F. Smoking attenuates wound inflammation and proliferation while smoking cessation restores inflammation but not proliferation. Wound Repair Regen 2010; 18: 186–92.
27. Sorensen LT, Toft B, Rygaard J, et al. Effect of smoking, smoking cessation, and nicotine patch on wound dimension, vitamin C, and systemic markers of collagen metabolism. Surgery 2010; 148: 982–90.
28. Nakagawa M, Tanaka H, Tsukuma H, Kishi Y. Determination of the duration of preoperative smoking cessation to improve wound healing after head and neck surgery. Anesthesiology 2005; 102: 892–6.
29. Barrera R, Shi W, Amar D, et al. Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. Chest 2005; 127 (6): 1977–83.
30. Goertz O, Kapalschinski N, Skorzinski T, et al. Wound healing complications in smokers, non-smokers and after abstinence from smoking. Chirurg 2012; 83: 652–6.
31. Mangat DS, Tansavatdi K, Garlich P. Current chemical peels and other resurfacing techniques. Facial Plast Surg 2011; 27 (1): 35–49.
32. Manassa EH, Hertl CH, Olbrisch RR. Wound healing problems in smokers and nonsmokers after 132 abdominoplasties. Plast Reconstr Surg 2003; 111: 2082–7.
33. Felton PM, Weaver TD. Phenol and alcohol chemical matrixectomy in diabetic versus nondiabetic patients. A retrospective study. J Am Podiatr Med Assoc 1999; 89: 410–2.
34. Giacalone VF. Phenol matrixectomy in patients with diabetes. J Foot Ankle Surg 1997; 36: 264–7.
© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. All world rights reserved.